- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05916170
A Study of Hookah Café Customers in the Atlanta Area
Communicating Waterpipe Tobacco Harms to Reduce Use Among Young Adults: A Study of Hookah Café Customers in the Atlanta Area
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Planning to enter the hookah café where study is being conducted
- Age 18 or older
- English speaking
- Planning to smoke hookah inside
- Not planning to smoke cigarettes, cigars, cigarillos or marijuana while at the hookah café
- Had not previously entered the café earlier in the day on the same day/night as data collection
- Has not been approached to participate in the study at another café or another day/night at the current café
- Are not employees of the business
- Have capacity to participate as determined by the staff member conducting eligibility screening
Exclusion Criteria:
- Not planning to enter the hookah café where the study is being conducted
- Age 17 and under
- Non-English speaking
- Not planning to smoke hookah in the café
- Planning to smoke cigarettes, cigars, or marijuana while at the hookah café
- Are employees of the business
- Had previously entered the café on the same day/night as data collection
- Has not been approached to participate in the study previously
- Does not have capacity to participate as determined by the staff member conducting eligibility screening
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control - No Warnings
No warnings posted in the hookah café
|
No warnings posted in the hookah café
|
|
Experimental: Intervention - Health Warnings
Cafes will display text-only warning signs
|
Text-only warnings about one health harm will be displayed in the hookah cafés where data collection is being conducted.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Expired Carbon Monoxide (eCO Boost)
Time Frame: Baseline and after exiting the café up to 10 hours
|
Change in eCO from baseline (before entry into the hookah café) to follow-up (upon exit from the hookah café) - eCO will be measured with the Bedfont Micro+ Smokerlyzer.
Higher scores represent higher concentrations of Carbon Monoxide (CO), which is correlated with greater waterpipe use.
|
Baseline and after exiting the café up to 10 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge
Time Frame: at exit; up to 10 hours
|
Four items to assess participants' knowledge of health harms based on warning statements used across the study. We will calculate a sum score for each individual with higher scores indicating more accurate knowledge. Response options: True / False / I don't know |
at exit; up to 10 hours
|
|
Beliefs
Time Frame: at exit; up to 10 hours
|
Four items to assess the participants' agreement with statements of how each of the four health harms utilized across the study apply to their own health. We will calculate a mean score across all four items for each individual, where higher scores indicate stronger beliefs about personal harm from hookah smoking. Response options: (1) Strongly disagree to (5) Strongly agree |
at exit; up to 10 hours
|
|
Behavioral Intention
Time Frame: at exit; up to 10 hours
|
Participants will be asked at three items assessing their anticipated hookah smoking within the next month. Items will be averaged to create a composite score of intent to continue the behavior within the next month.
|
at exit; up to 10 hours
|
|
Quit Motivation
Time Frame: at exit; up to 10 hours
|
One item to measure participants' motivation to quit smoking hookah, rated on a 1-10 scale of Not at all motivated to Extremely motivated
|
at exit; up to 10 hours
|
|
Hookah Use Behavior
Time Frame: at exit; up to 10 hours
|
Participants will be asked a variety of items to assess their hookah smoking behaviors within the café. Items will be scored individually.
|
at exit; up to 10 hours
|
|
Subjective Experiences of Smoking Hookah
Time Frame: at exit; up to 10 hours
|
Eight items from the Product Evaluation Scale (Hatsukami et al. 2013) will be used to assess participants' subjective experiences of smoking hookah. Items scores will be averaged across the subscale.
|
at exit; up to 10 hours
|
|
Warning Recall
Time Frame: at exit; up to 10 hours
|
One Y/N item to assess participants' exposure to warnings.
If participants report warning exposure, an open-ended item will assess warning recall.
|
at exit; up to 10 hours
|
|
Warning Recognition
Time Frame: at exit; up to 10 hours
|
Participants in the intervention arm will be asked to select the warning(s) that they saw at the café from four possible warnings.
For each warning message that they report having seen, they will be asked to select where they saw the warning from a list of possible locations.
(Intervention arm only)
|
at exit; up to 10 hours
|
|
Social Interaction
Time Frame: at exit; up to 10 hours
|
For each warning selected in the Warning Recognition section, participants will be asked if they discussed the warning with others.
If they answer positively, they will be given a list of topics to choose from to describe what they talked about, including a free-text option.
|
at exit; up to 10 hours
|
|
Perceived Influence of Warning on Smoking Behavior Answers
Time Frame: at exit; up to 10 hours
|
Participants will be asked whether they changed their smoking behavior as a result of the warning(s) they saw (as reported in the Warning Recognition section).
They will be asked to report whether they smoked more, less, or the same amount as they usually do.
These items will be asked for each warning the participant reports seeing.
|
at exit; up to 10 hours
|
|
Time Spent in the café
Time Frame: at exit; up to 10 hours
|
Duration of time in café will be calculated from the time of completion of eCO measurement at Time 1 to start of survey at Time 2. Additionally, we will utilize a subjective measure of time spent in the café: Compared to what you planned, how long did you stay at the café/lounge/bar?
(Longer, shorter, about the same).
|
at exit; up to 10 hours
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Erin Sutfin, PhD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00095123
- R01CA241420 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Waterpipe Tobacco Smoking
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedWaterpipe Tobacco SmokingUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedWaterpipe Tobacco SmokingUnited States
-
Florida International UniversityCompleted
-
Washington State UniversityCompleted
-
University of OklahomaNational Institute on Drug Abuse (NIDA); American University of Beirut Medical... and other collaboratorsCompletedWaterpipe Smoking | Smoking, HookahUnited States
-
San Diego State UniversityCompleted
-
Ataturk Training and Research HospitalCompletedOxidative Stress | Waterpipe Smoking
-
Rambam Health Care CampusCompletedWaterpipe SmokingIsrael
-
Florida International UniversityCompletedHealth Risk Behaviors | Waterpipe Smoking | Health Warning Label | Harm Perception | Puffing Behaviour | Quitting SmokingUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
Clinical Trials on No Warnings
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedWaterpipe Tobacco SmokingUnited States
-
Hitotsubashi UniversityGlobal Public Health Research FoundationRecruitingHypertension | Tobacco Cessation | Health Warning Label | Non Communicable Chronic DiseasesBangladesh
-
Boston UniversityNational Cancer Institute (NCI); Brown University; National Institutes of Health... and other collaboratorsCompleted
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Completed
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
University of South CarolinaCornell University; University of Waterloo; University of TasmaniaCompleted
-
Boston UniversityNational Cancer Institute (NCI); Brown University; Wake Forest University Health...Completed
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
University of California, San FranciscoNational Cancer Institute (NCI); National Institutes of Health (NIH)Enrolling by invitationColorectal Cancer | Colon Cancer | Cancer ColorectalUnited States
-
RadiancyCompletedMild to Moderate Chronic Low Back PainIsrael